최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기精神身體醫學 = Korean journal of psychosomatic medicine, v.26 no.2, 2018년, pp.119 - 126
권지웅 (인제대학교 의과대학 일산백병원 정신건강의학교실) , 김현 (인제대학교 의과대학 일산백병원 정신건강의학교실) , 이강준 (인제대학교 의과대학 일산백병원 정신건강의학교실)
Objectives : The aim of this study is to investigate correlation between degree of white matter hyperintensities (WMH) and neurocognitive function along with behavioral and psychological symptoms of dementia (BPSD) in Korean patients with Alzheimer's disease (AD) and mild cognitive impairment (MCI)....
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
알츠하이머 병은 전체 치매 유형 중 얼마의 비율을 차지하는가 | 치매는 만성 및 진행성 뇌질환 증후군으로 뇌병변의 발생 및 진행으로 인해 기억력, 판단력, 실행 능력을 포함한 인지 기능의 장애와1) 불안, 초조, 배회, 망상 등과 같은 행동심리 증상(Behavioral and Psychological Symptoms of Demen-tia, BPSD)이 함께 나타나는2) 기질성 정신장애이다. 다양한 뇌 손상에 의해서 치매가 발병할 수 있으나 가장 대표적인 원인 질환은 알츠하이머 병(Alzheimer’s disease, AD)으로 전체 치매 유형 중 71%를 차지하고 있다. 또한 치매의 전단 계로 알려진 경도인지장애(Mild cognitive impairment, MCI)도 관심의 초점이 되고 있다. | |
치매란 무엇인가 | 치매는 만성 및 진행성 뇌질환 증후군으로 뇌병변의 발생 및 진행으로 인해 기억력, 판단력, 실행 능력을 포함한 인지 기능의 장애와1) 불안, 초조, 배회, 망상 등과 같은 행동심리 증상(Behavioral and Psychological Symptoms of Demen-tia, BPSD)이 함께 나타나는2) 기질성 정신장애이다. 다양한 뇌 손상에 의해서 치매가 발병할 수 있으나 가장 대표적인 원인 질환은 알츠하이머 병(Alzheimer’s disease, AD)으로 전체 치매 유형 중 71%를 차지하고 있다. | |
백질 고강도 신호는 몸의 어떤 기능과 관련이 있는가 | 백질 고강도 신호(white matter hyperintensity, WMH)는 건강한 노인, 경도인지장애 및 알츠하이머병 환자에서 인지 기능 저하의 예측 인자로서 연구되어 왔다.5)정상적인 노화 에서 WMH은 지연된 기억, 처리 속도 및 실행 기능의 수행 저하와 관련이 있는 것으로 보고되고 있다.6) 일부 비치매 인구 기반 연구에서 WMH이 있는 경우 인지기능 감소 확률이 더 높은 것으로 예측되었다. |
Park YS, Suk MS. The improvement plan of social welfare service for advancing family resilience of caring dementias. J Korean Soc Welf Adm 2002;6:119-144.
Kim JM, Shin IS, Yoon JS. Determinants of care burden of caregiver inpatients with dementia. J Korean Neuropsychiatr Assoc 2001;40:1006-1013.
Glenner GG, Wong CW. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Alzheimer Dis Assoc Disord 1988;2:134.
Westman E, Simmons A, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kloszewska I, Soininen H, Weiner MW, Lovestone S, Spenger C, Wahlund LO. AddNeuroMed and ADNI: similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America. Neuroimage 2011;58:818-828.
Burns JM, Church JA, Johnson DK, Xiong CJ, Marcus D, Fotenos AF, Snyder AZ, Morris JC, Buckner RL. White matter lesions are prevalent but differentially related with cognition in aging and early Alzheimer disease. Arch Neurol 2005; 62:1870-1876.
Gunning-Dixon FM, Raz N. The cognitive correlates of white matter abnormalities in normal aging: A quantitative review. Neuropsychology 2000;14:224-232.
De Groot JC, De Leeuw FE, Oudkerk M, Van Gijn J, Hofman A, Jolles J, Breteler MM. Periventricular cerebral white matter lesions predict rate of cognitive decline. Ann Neurol 2002;52:335-341.
Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease-the nun study. JAMA 1997;277: 813-817.
Prins ND, van Dijk EJ, den Heijer T, Vermeer SE, Koudstaal P, Oudkerk M, Hofman A, Breteler MM. Cerebral white matter lesions and the risk of dementia. Arch Neurol 2004;61: 1531-1534.
Chen TF, Chen YF, Cheng TW, Hua MS, Liu HM, Chiu MJ. Executive Dysfunction and periventricular diffusion tensor changes in amnesic mild cognitive impairment and early Alzheimer's disease. Hum Brain Mapp 2009;30:3826-3836.
Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2010;341:c3666.
Verdelho A, Madureira S, Moleiro C, Ferro JM, Santos CO, Erkinjuntti T, Pantoni L, Fazekas F, Visser M, Waldemar G, Wallin A, Hennerici M, Inzitari D. White matter changes and diabetes predict cognitive decline in the elderly: the LADIS study. Neurology 2010;75:160-167.
Taylor ME, Lord SR, Delbaere K, Wen W, Jiang J, Brodaty H, Kurrle SE, Stefanie Mikolaizak A, Close JCT. White matter hyperintensities are associated with falls in older people with dementia. Brain Imaging Behav 2018;25:1-8.
O'Brien JT. Vascular cognitive impairment. Am J Geriatr Psychiatry 2006;14:724-733.
Jellinger KA. Small concomitant cerebrovascular lesions are not important for cognitive decline in severe Alzheimer disease. Arch Neurol 2001;58:520-521.
Esiri MM, Nagy Z, Smith MZ, Barnetson L, Smith AD. Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet 1999;354:919-920.
Kang DW, Lim HK. Current Knowledge and Clinical Application of Brain Imaging in Alzheimer's Disease. J Korean Neuropsychiatr Assoc 2018;57:12-22.
Harper L, Barkhof F, Fox NC, Schott JM. Using visual rating to diagnose dementia: a critical evaluation of MRI atrophy scales. J Neurol Neurosurg Psychiatry 2015;86:1225-1233.
Gao FQ, Swartz RH, Scheltens P, Leibovitch FS, Kiss A, Honjo K, Black SE. Complexity of MRI white matter hyperintensity assessments in relation to cognition in aging and dementia from the Sunnybrook Dementia Study. J Alzheimers Dis 2011;26:379-388.
Hart DJ, Craig D, Compton SA, Critchlow S, Kerrigan BM, McIlroy SP, Passmore AP. A retrospective study of the behavioural and psychological symptoms of mid and late phase Alzheimer's disease. Int J Geriatr Psychiatry 2003;18:1037-1042.
Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA 2002;288:1475-1483.
Piccininni M, Di Carlo A, Baldereschi M, Zaccara G, Inzitari D. Behavioral and psychological symptoms in Alzheimer's disease: frequency and relationship with duration and severity of the disease. Dement Geriatr Cogn Disord 2005;19:276-281.
Berlow YA, Wells WM, Ellison JM, Sung YH, Renshaw PF, Harper DG. Neuropsychiatric correlates of white matter hyperintensities in Alzheimer's disease. Int J Geriatr Psychiatry 2010;25:780-788.
Rosen HJ, Allison SC, Schauer GF, Gorno-Tempini ML, Weiner MW, Miller BL. Neuroanatomical correlates of behavioural disorders in dementia. Brain 2005;128(Pt 11):2612-2625.
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Backman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, De-Carli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC. Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004;256:240-246.
Kono I, Mori S, Nakajima K, Nakagawa M, Watanabe Y, Kizu O, Yamada K, Sakai Y. Do white matter changes have clinical significance in Alzheimer's disease? Gerontology 2004; 50:242-246.
Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987;149:351-356.
Kwon YC, Park JH. Korean version of Mini-Mental State Examination (MMSE-K) part I: Development of the test for the elderly. J Korean Neuropsychiatr Assoc 1989;28:125-135.
Morris JC. The clinical Dementia rating (CDR): current version and scoring rules. Neurology 1993;43:2412-2414.
Reisberg B, Ferris SH, de Leon MJ, Crook T. Global Deterioration scale (GDS). Psychopharmacol Bull 1988;24:661-663.
Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory : comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308-2314.
Bae JN, Cho MJ. Development of the Korean version of the Geriatric Depression scale and its form among elderly psychiatric patients. J psychosom Res 2004;57:297-305.
Michaela D, Josef M, Eberhard D, Gerog K, Tanja D, Michael S. Impact of White Matter Lesions and Cognitive Deficits on Conversion from Mild Cognitive Impairment to Alzheimer's Disease. Journal of Alzheimer's Disease 2013;34: 665-672.
Ogawa Y, Hashimoto M, Yatabe Y, Kaneda K, Honda K, Yuuki S, Hirai T, Ikeda M. Association of cerebral small vessel disease with delusions in patients with Alzheimer's disease. Int J Geriatr Psychiatry 2013;28:18-25.
Miranda B, Madureira S, Verdelho A, Ferro J, Pantoni L, Salvadori E, Chabriat H, Erkinjuntti T, Fazekas F, Hennerici M, O'Brien J, Scheltens P, Visser MC, Wahlund LO, Waldemar G, Wallin A, Inzitarion D; LADIS Study. Selfperceived memory impairment and cognitive performance in an elderly independent population with age-related white matter changes. J Neurol Neurosurg Psychiatry 2008;79:869-873.
Prins ND, van Dijk EJ, den Heijer T, Vermeer SE, Jolles J, Koudstaal PJ, Hofman A, Breteler MM. Cerebral smallvessel disease and decline in information processing speed, executive function and memory. Brain 2005;128:2034-2041.
Jokinen H, Gouw AA, Madureira S, Ylikoski R, van Straaten EC, van der Flier WM, Barkhof F, Scheltens P, Fazekas F, Schmidt R, Verdelho A, Ferro JM, Pantoni L, Inzitari D, Erkinjuntti T. Incident lacunes influence cognitive decline: the LADIS study. Neurology 2011;76:1872-1878.
de Groot JC, de Leeuw FE, Oudkerk M, Hofman A, Jolles J, Breteler MM. Cerebral white matter lesions and subjective cognitive dysfunction: the Rotterdam Scan Study. Neurology 2001;56:1539-1545.
Tullberg M, Fletcher E, DeCarli C, Mungas D, Reed BR, Harvey DJ, Weiner MW, Chui HC, Jagust WJ. White matter lesions impair frontal lobe function regardless of their location. Neurology 2004;63:246-253.
Choi L, Joo SH, Lee CU, Paik IH. Association between Global Cortical Atrophy, Medial Temporal Atrophy, White Matter Hyperintensities and Cognitive Functions in Korean Alzheimer's Disease Patients. Korean J Biol Psychiatry 2015;22:140-148
Duffy JD, Campbell JJ 3rd. The regional prefrontal syndromes: a theoretical and clinical overview. J Neuropsychiatry Clin Neurosci 1994;6:379-387.
Tekin S, Cummings JL. Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. J Psychosom Res 2002; 53:647-654.
Nagaendran K, Russel C, Angeline Z, Cheong CY. Cerebral white matter disease is independently associated with BPSD in Alzheimer's disease. Journal of the Neurological Sciences 2014;337:162-166.
Clark LM, McDonald WM, Welsh-Bohmer KA, Siegler IC, Dawson DV, Tupler LA, Krishnan KR. Magnetic resonance imaging correlates of depression in early- and late-onset Alzheimer's disease. Biol Psychiatry 1998;44:592-599.
Starkstein SE, Sabe L, Vazquez S, Di Lorenzo G, Martinez A, Petracca G, Teson A, Chemerinski E, Leiguarda R. Neuropsychological, psychiatric, and cerebral perfusion correlates of leukoaraiosis in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1997;63:66-73.
Harrell LE, Duvall E, Folks DG, Duke L, Bartolucci A, Conboy T, Callaway R, Kerns D. The relationship of high-intensity signals on magnetic resonance images to cognitive and psychiatric state in Alzheimer's disease. Arch Neurol 1991;48: 1136-1140.
Son SJ, Lee KS, lee YH, Baek JH, Choi SH, Na DL, Seo SW, Oh BH, Hong CH. Assoication between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ${\varepsilon}4$ allele in the elderly: retrospective analysis of data from the CREDOS study. (2015). J Clin Psychiatry 2012;73:1555-1562.
Treiber KA, Lyketsos CG, Corcoran C, Steinberg M, Norton M, Green RC, Rabins P, Stein DM, Welsh-Bohmer KA, Breitner JC, Tschanz JT. Vascular factors and risk for neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study. Int Psychogeriatr 2008;20:538-553.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.